本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Dianthus Therapeutics Inc.

106.20
+2.922.83%
盤後106.200.00000.00%19:30 EDT
成交量:73.28萬
成交額:7,853.88萬
市值:59.40億
市盈率:-25.82
高:109.79
開:106.78
低:105.00
收:103.28
52周最高:117.88
52周最低:32.22
股本:5,593.44萬
流通股本:5,585.01萬
量比:1.15
換手率:1.31%
股息:- -
股息率:- -
每股收益(TTM):-4.1130
每股收益(LYR):-4.2037
淨資產收益率:-26.07%
總資產收益率:-17.69%
市淨率:5.07
市盈率(LYR):-25.26

資料載入中...

2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/27

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/26

重要事件披露

Form 8-K - Current report
2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/09

重要事件披露

Form 8-K - Current report
2026/03/09

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/30

SEC問詢函

Form CORRESP - Correspondence